08048036251

Letfit 2.5 mg Tab is a branded tablet product that should be verified for its exact active ingredient and manufacturer before publication. If it contains letrozole 2.5 mg, it belongs to the aromatase inhibitor class and is used under medical supervision to treat certain hormone-sensitive breast cancers, particularly in postmenopausal women. Letrozole works by reducing estrogen production in the body, which may help slow the growth of estrogen-dependent cancer cells. Treatment suitability depends on the patient's diagnosis, medical history, and healthcare professional's assessment. Possible side effects include hot flashes, joint pain, fatigue, headache, and increased sweating. Long-term use may affect bone density, so appropriate monitoring may be necessary. This prescription medicine should be taken only as directed by a qualified healthcare professional. Patients should not change the dose or begin treatment without medical advice. Store the product according to the manufacturer's instructions and verify its composition before distribution. Phoenix Exim, based in India, handles pharmaceutical export enquiries subject to product verification and applicable export and import regulations.


CONTACT PHOENIX EXIM


Contact No. / WhatsApp: +91-9307610860 & +91-9860818372
Email: phoenixexim2000@gmail.com

Oct 15th, 2026 3:41 PM